Londoni börsil noteeritud AstraZeneca, mis on tuntud oma vähiravi, diabeediravimite ja COVID-19 vaktsiini poolest, teatas esmaspäeval, et investeerib 2030. aastaks 50 miljardit dollarit (42,6 miljardit eurot) ravimite tootmiseks Ameerika Ühendriikides.

:format(webp)/nginx/o/2025/11/12/17272850t1h8723.jpg)
:format(webp)/nginx/o/2025/11/12/17272844t1h14a3.jpg)
:format(webp)/nginx/o/2025/11/10/17269480t1h5c53.jpg)
/nginx/o/2025/11/11/17271962t1h9038.jpg)
/nginx/o/2025/11/11/17272222t1h6285.jpg)
/nginx/o/2025/07/22/17021754t1h25bf.jpg)
:format(webp)/nginx/o/2025/11/11/17272168t1hb414.jpg)
:format(webp)/nginx/o/2025/07/09/16990125t1hc488.jpg)
:format(webp)/nginx/o/2022/02/09/14354904t1h6c68.jpg)
/nginx/o/2025/11/11/17272623t1h96db.jpg)
:format(webp)/nginx/o/2024/04/23/16026134t1h0a19.jpg)
/nginx/o/2025/11/11/17271603t1h84ed.jpg)
:format(webp)/nginx/o/2024/11/11/16477868t1hc470.jpg)
:format(webp)/nginx/o/2025/10/13/17207508t1he4ed.jpg)
/nginx/o/2025/09/25/17170686t1h29a8.jpg)